• Pediatric Infection and Vaccine
• /
• 제15권1호
• /
• pp.1-4
• /
• 2008

Immunizations are among the most cost-effective and widely used public health interventions. This is a report a revision of recommendation of immunization for children by Korean Pediatric Society. Immunization. Vaccines were divided into 4 groups. 1) Vaccines that are recommended to all infants and children (BCG, hepatitis B vaccine, DTaP, Td, Polio vaccine, Japanese encephalitis vaccine, MMR, varicella vaccine, influenza vaccine [6-23 months of age], H. influenzae type b vaccine), 2) those that can be administered to all infants and children, but decision of administration is made by parents (pneumococcal conjugate vaccine, hepatitis A vaccine, influenza vaccine [healthy children ${\geq}24$ months of age], rotavirus vaccine, human papilloma virus vaccine), 3) those that should be given to high risk group (pneumococcal polysaccharide vaccine [high risk patients ${\geq}24$ months of age], influenza vaccine [high risk patients ${\geq}24$ months of age], typhoid vaccine), and 4) those administered for control of outbreaks or prevention of emerging infectious diseases. Immunization schedule recommended by Korean Pediatric Society in 2008 is presented.

• KSII Transactions on Internet and Information Systems (TIIS)
• /
• 제9권4호
• /
• pp.1392-1403
• /
• 2015

The rapid development of both communication traffic and increasing optical network sizes has increased energy consumption. Traditional algorithms and strategies don't apply to controlling the expanded network. Immunization algorithms originated from the complex system theory are feasible for large-scale systems based on a scale-free network model. This paper proposes the immunization strategy for complex systems which includes random and targeted immunizations to solve energy consumption issues and uses traffic to judge the energy savings from the node immunization. The simulation results verify the effectiveness of the proposed strategy. Furthermore, this paper provides a possibility for saving energy with optical transmission networks.

• Biomolecules & Therapeutics
• /
• 제2권4호
• /
• pp.326-330
• /
• 1994

The treatment of pseudomonal infection is a perplexed problem because of its modest susceptibility to most of the major antibiotics. A novel Pseudomonas vaccine(CFC-101) was prepared from the outer membrane protein fractions of several Pseudomonas strains. In this study, we examined CFC-101's effectiveness in both active and passive immunization models. CFC-101 in mice at 0.2 mg/kg, i.p., given three times at two-day intervals, completely prevented the death caused by Pseudomonas aeruginosa. Antibody titer, in accordance with the protective effect in this active immunization, was elevated to its peak level following three consecutive administrations of CFC-101. Thereafter, antibody titer stayed at a constantly high level. Each outer membrane protein fraction from the four CFC-101 producers, exhibited good cross-protective effects in mouse infection models against different Fisher types of P. aeruginosa. In the passive immunization model, 21~336 $\mu\textrm{g}$/kg of anti-rabbit IgG to CFC-101, when mice being infected with a challenge strain, prevented the Pseudomonhas-induced death up to 60%. Therefore, the preventive effect of CFC-101 was verified in both the active and passive immunization models.

• 한국보건간호학회지
• /
• 제23권1호
• /
• pp.113-128
• /
• 2009

Purpose: To explore the barriers and solutions of immunization programs for children among vulnerable classes in the position of service providers in Community health centers. Method: Data were collected through focus group interviews with 3 groups (17 providers), and were analyzed according to the analytic method of Morgan (1998) and Krueger (1998). Results: The following five categories were identified: difficulties in obtaining a list of children among vulnerable classes, difficulties in first contact with them, difficulties in up-to-date immunization, various difficulties according to the types of vulnerable family and suggestions of solution. These results indicated that there are many difficulties in providing expanded immunization service for children among vulnerable classes in terms of manpower, cooperation of departments in public health centers and linkages between health and welfare. Finally, the characteristics of the types of vulnerable family need to be elucidated. Conclusion: To increase immunization rates among children of vulnerable classes, policies need to be prepared at the public health organization itself and the linkages between health and welfare and need for hiring additional personnel.

• 한국축산식품학회지
• /
• 제25권3호
• /
• pp.333-339
• /
• 2005

난황 항체 강화를 위하여 켈프밀 $4\%$ 처리구와 계피 $0.3\%$와 박하 $2\%$가 첨가된 특수사료를 급여하고 Streptococcus mutans를 2주 간격의 5회 면역처리를 복합적으로 실시하면서 40주령 산란계를 사양하였다. 면역처리를 하지 않은 처리군에서는 박하 첨가군의 산란율이 높았다. 면역한 후에 발생되는 산란율 저하는 대조구와 계피 첨가군에서 적게 나타났다. 계란의 무게는 면역처리에 따른 효과가 나타나지 않았으나 사료에 따라 차이가 나타났다. 면역처리를 하지 않은 처리구에서 계피, 박하, 켈프밀 모두 총 IgY 함량이 대조구보다 높게 나왔으며, 특히 켈프밀의 경우 대조구에 비해 $5.4\%$ 가량 상승하였다. 면역 한 처리구끼리 각각 비교하여 보면 대조구에 비해서 다른 처리구에서 모두 높았으며, 특히 켈프밀 처리구가 월등히 높아 대조구에 비해 $7.9\%$ 정도의 상승이 있었다. S. mutans로 면역처리된 닭으로부터 얻은 계란에서의 충치균에 대한 특이(specific) 총 IgY 함량을 분석한 결과, 항충치균 IgY는 1차 면역하고 4주정도 후에 나타나기 시작하였다. 마지막 immunization후 5주 이상 경과하더라도 specific IgY의 양이 상당히 높은 수준을 유지하는 것을 볼 수 있었다. 총 실험기간 동안의 specific IgY 함량의 평균을 보면 켈프밀 처리구는 다른 식이에서 보다 훨씬 높은 specific IgY 역가 보여주었고 대조구에 비해 특이 항체가 약 $8.5\%$ 가량 증가되어 켈프밀의 첨가는 면역처리를 통한 특수 IgY 생산에 효과적임을 나타내었다

• 농촌의학ㆍ지역보건
• /
• 제23권2호
• /
• pp.205-213
• /
• 1998

In order to find out the status of routine-immunization in a rural area, this study was performed, through analyzing the data which was obtained from the immunization register of infants who was born at Su-Dong myun in 1996 and 1997, managed by Su-dong Myun health subcenter. The results are as follows. 1. B.C.G immunization rate was the highest such as 52.2% within 1 month and next order such 34.8% at 2 month in 1996. In 1997, the highest such as 73.8%, almost all, within 1 month. 2. D.P.T immunization rate in 1996 showed, almost all, the highest at 3 month(79.4%) for 1st dose and at 5 month(78.4%) for 2nd dose. However, the rate for 3rd dose showed the highest at 7 month(51.4%), and next order at 8 month(35.1%) and at 6 month(13.5%). D.P.T immunization rate in 1997, similarly showed the highest at 3 month(81.8%) for 1st dose, at 5 month(71.2%) for 2nd dose and at 7 month(71.4%) for 3rd dose. 3. Hepatitis B immunization rate showed the highest at birth at once or within one week(87.0%) for 1st dose in 1996 and (94.7%) in 1997. The rate for 2nd dose showed the highest at 2 month(51.7%) in 1996 and (50.0%) in 1997, and next order at 1 month(44.8%) in 1996 and (34.4%) in 1997. The rate for 3rd dose showed the highest at 3 month(54.8%) in 1996 and 5 month(54.8%) in 1997, and next order at 5 month(25.8%) in 1996 and at 3 month(26.0%) in 1997. 4. Measles immunization rate was 76.1% in 1996. The rate(76.1%) by the kind of vaccine was the highest with measles-MMR(34.8%), and with MMR(32.6%) and next order with measles(8.7%). The rate by measles immunization time(month) was the highest such as 35.0% at 9 month and 10 month respectively and the rate by MMR was the highest at 16 month(35.5%), and 15 month(22.5%), 13 month (12.9%) and 14 month(12.9%) in next order.

• Journal of Microbiology and Biotechnology
• /
• 제10권6호
• /
• pp.865-872
• /
• 2000

Helocobacter phylori is the major cause of gastritis, peptic ulcer, and a principal risk factor for gastric cancer. As the firs step towards a vaccine against H. pylori infection, Hy.pylori urease was expressed and purified as a recombinant apoenzyme (rUrease) in E. coli. In order to develop an effective immunization protocol using rUrease, the host immune responses were evaluated after the oral immunization of mice with rUrease preparations plus cholera toxin relative to various conditions, such as the physical nature of the antigen, the frequency of the booster immunization, the dose of the antigen, and the route of administration. The protective efficacy was assessed using a quantitative culture following an H. pylori SS1 challenge. It was demonstrated that rUrease, due to its particulated nature, was more superior than the UreB subunit as a vaccine antigen. The oral immunization of rUrease elicited significant systemic and secretory antibody responses, and activated predominantly Th2-type cellular responses. The bacterial colonization was significantly reduced (~100-fold) in those mice immunized with three or four weekly oran doses of rUrease plus cholera toxin (p<0.05), when compared to the non-immunized/challenged controls. The protection correlated well with the elicited secretory IgA level against rUrease, and these secretory antibody responses were highly dependent on the frequency of the booster immunization, yet unaffected by the dose of the antigen (25-200$\mu\textrm{g}$). These results demonstrate the remarkable potential of rUrease as a vaccine antigen, thereby strengthening the possibility of developing an H. pylori vaccine for humans.

• Clinical and Experimental Pediatrics
• /
• 제56권6호
• /
• pp.231-234
• /
• 2013

This article contains the recommended immunization schedule by the Committee on Infectious Diseases of the Korean Pediatric Society, updated in March 2013, when Haemophilus influenzae type b vaccine is now included in the National Immunization Program in Korea. It also includes catch-up immunization schedule for children and adolescents who are behind the recommended schedule. These schedules are a minor revision of the corresponding parts of Immunization Guideline, 7th edition, of the Korean Pediatric Society, released in 2012. Pediatricians should be aware of these schedules to provide adequate immunization to Korean children and adolescents.

• 농촌의학ㆍ지역보건
• /
• 제29권1호
• /
• pp.65-75
• /
• 2004

현재 보건소를 중심으로 이루어지고 있는 예방접종 등록사업은 향후 전국의 민간의료기관에 확산 적용되어 공공보건의료기관과 민간의료기관이 상호 연계되고 데이터가 통합, 운영됨으로써 국가예방접종사업이 완성될 수 있다. 따라서 민간의료기관에 기반한 예방접종 사업의 정보화 추진에서의 발생할 수 있는 문제점들을 예측하고 이를 해결할 수 있는 성공전략을 개발하는 것은 매우 중요하다. 그 중에서도 민간의료기관이 Non-chart system의 예방접종 모듈을 분석하여 예방접종 전산화를 위한 기본적인 문제점과 개선방안을 도출하고 공공보건의료기관과의 통합적 연계운영을 위한 기초자료를 제공하는 것은 예방접종전산등 곡사업의 핵심사업과제중의 하나이다. 예방접종 정보관련 프로그램을 평가하기 위하여 현재 민간의료기관(내과, 소아과, 산부인과 및 가정의학과)에서 주로 사용하고 있는 4개 보험청구 및 진료기록관리 프로그램인 Non-chart system과 현재 보건소에서 사용하고 있는 예방접종등록정보 프로그램인 (주)포스테이터의 보건소정보시스템과 (주)미드컴퓨터의 예방접종등록시스템 두가지를 대상으로 하였다. 분석의 표준은 현재 보건소에서 사용하고 있는 예방접종 관련 소프트웨어를 중심으로 하여 민간의료기관의 예방접종관련 프로그램 및 관련 모듈을 분석하였다. 모듈의 분석은 보건소정보시스템 및 예방접종 등록 프로그램을 기본으로 하여 예방접종 업무의 흐름과 활용 및 기능에 따라 분석하였다. 접수 및 신상등록에 있어서 기본적인 자료의 입력내용이 민간의료기관의 내용을 기준으로 보완됨이 바람직할 것으로 보여지는 데 특히 추후 검색과 리마인드(reminder) 및 리콜(Recall)기능의 이용을 대비하여 E-mail주소 등 개인신원의 내용을 충분히 파악할 필요가 있다고 판단된다. 예방접종 예진부분은 모든 프로그램에서 누락되어 있는데 필수적인 예진표의 내용을 반드시 포함시킬 필요가 있다. 개인의 접종기록 및 검색은 개인별 접종표 화면이 출력과 필수적인 접종내역란이 구성으로 접종표 형식이 단순화되어 사용하기에 편리하게 구성되어야 할 것이다. 접종대상 및 실적보고 서식 출력은 법령에 따라 Non-chart system을 이용한 자동화된 전산처리가 가능하여야 하며 자동화된 출력서식의 모듈이 제공되어야한다. 예방접종 증명서 발급기능은 2005년 이후부터 초등학교 입학시 예방접종증명서 제출 의무화가 예정되어 있으므로 예방접종 증명서의 발급기능이 추가되어야 한다. 접종자료의 전송기능으로는 의료보험의 EDI 청구를 위한 전송기능을 이용한 기능이 추가되어야하며 추후 예방접종 자료의 DB변환과 더불어 전송될 수 있는 기능이 추가되어야 한다. 리마인드(Reminder) 및 리콜(Recall)기능은 예방접종 등록사업의 필수적인 부분이며, E-mail을 통한 방법, 전화 또는 편지를 발송하는 방법 등이 추가되어야한다. 백신의 등록 및 재고관리 기능은 다양한 제약회사의 백신생산 및 백신의 효율적인 공금과 유효기간내 접종 등 관리와 견제되므로 백신등록 추가기능이 필요하며 아울러 연령별, 용량별, 백신종류별 등으로 구분되어 기록될 필요가 없었다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권6호
• /
• pp.3515-3519
• /
• 2013

Background: Effects of whole cell type immunization on mice Ehrlich tumours were evaluated. Materials and Methods: After preliminary study, mice were divided two major groups; $1{\times}1000$ and $100{\times}1000$ live Ehrlich cell transferred major groups, each divided into four subgroups (n: 10). Study groups were immunized with Ehrlich cell lysates in 0, 3, 7, $14^{th}$ days and after 30 days of last immunization, live Ehrlich cells were transferred. Mice were observed for six months and evaluated for total and cancer free days. Results: Out of $100{\times}1000$ cell transferred solid type study group, all study group mean and tumour free periods were statistically longer than control groups. All $1{\times}1000$ Ehrlich cell transferred study groups survived significantly longer than $100{\times}1000$ Ehrlich cell transferred groups. Conclusions: Ehrlich mice tumours were prevented and survival prolonged with whole cell type immunization. Effects are related to the number of transferred tumor cells.